Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Kite Pharma, Inc. (KITE)

« Back to company index

KITE Chatter Timeline

Stock Ticker for KITE

Most Active Tweeters for KITE

UserTweets
@dhovekamp42 1
@BursatilBiotech 1

Recent Tweets for KITE

dhovekamp42 @dhovekamp42
RT @BursatilBiotech: Get well soon, King $KITE! This market needs you, @Arie_Belldegrun ? https://t.co/EwMj2KipBn
March 14th 2020, 8:03pm
BursatilBiotech @BursatilBiotech
Get well soon, King $KITE! This market needs you, @Arie_Belldegrun ? https://t.co/EwMj2KipBn
March 14th 2020, 3:03am
lblegend33 @lblegend33
@brendan_49 What do u think $kite would be at if $gild didn’t buy them? ?
March 13th 2020, 1:03pm
PresyFelix @PresyFelix
@_don_sparrow Hi $Kite, thanks for the tip
March 5th 2020, 3:03am
jianguangchen @jianguangchen
Buying $KITE is a mistake for $GILD. Instead of admitting mistake and cutting loss, the management just pile on m… https://t.co/MHu9QJf32w
March 2nd 2020, 12:03pm
RCR52 @RCR52
@OnlyBios It's a great move for $Gild they paid less then 5 billion for a company with a Huge pipeline. They will compliment $Kite
March 2nd 2020, 7:03am
jeromeleonard5 @jeromeleonard5
@OnlyBios After paying 11B for $kite, at least it's an improvement
March 2nd 2020, 7:03am
RiddaKilla76 @RiddaKilla76
@ag76_biotech $SGMO wants that $KITE type money and less large pharmas are willing to pay up at the moment. But it’s coming.
February 27th 2020, 11:02pm
sunrgu @sunrgu
@zbiotech This will be another mistake like $KITE
February 27th 2020, 4:02pm
RCR52 @RCR52
@dmshetayh BTW good things happening in the immunotherapy division of Gilead with the purchase of $Kite a few years… https://t.co/aSwMo4lL6s
February 21st 2020, 10:02pm
MDegn67 @MDegn67
The real future in cell therapy / listen to former $KITE co-founder David Chang in this $ALLO presentation. from 21… https://t.co/zDDbC9ok0d
February 12th 2020, 8:02am
joaquinkam @joaquinkam
RT @BioStocks: $GILD FDA Grants Priority Review for KTE-X19 BLA in Relapsed or Refractory Mantle Cell Lymphoma. PDUFA 08/10/20 $KITE
February 10th 2020, 8:02am
BioStocks @BioStocks
$GILD FDA Grants Priority Review for KTE-X19 BLA in Relapsed or Refractory Mantle Cell Lymphoma. PDUFA 08/10/20 $KITE
February 10th 2020, 8:02am
tuduylinh @tuduylinh
@matthewherper $gild was desperate as HCV revs plateaued & trended down from high , so in that state of mind $kite… https://t.co/dr4zUcz7YE
February 5th 2020, 10:02am
PredatorDiaries @PredatorDiaries
@NedPagliarulo Yeah, but look what the $11.9bn spent on $KITE got 'em.
February 4th 2020, 4:02pm
PredatorDiaries @PredatorDiaries
@DrPaulyDeSantis @dsobek How much did they buy $KITE for?
February 4th 2020, 4:02pm
AGCT_team @AGCT_team
RT @BertrandBio: B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 2/x west coast facility…
February 3rd 2020, 4:02pm
tomorrowdaworld @tomorrowdaworld
RT @BertrandBio: B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 5/x site qualification…
February 2nd 2020, 10:02am
JanEhses @JanEhses
RT @BertrandBio: B Dudek Head Quality EU @ $KITE / $GILD - Expanding CAR T into the commercial setting: Planning for success #CART2020 1/x…
February 2nd 2020, 3:02am
BertrandBio @BertrandBio
$KITE $GILD "we're still working with some boutique suppliers, not all used to supply GMP quality materials"… https://t.co/W5d8o3PwoA
February 1st 2020, 10:02am
BehaviorFin @BehaviorFin
RT @BertrandBio: B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 6/x conclusion https://…
February 1st 2020, 10:02am
BertrandBio @BertrandBio
B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 6/x conclusion https://t.co/FEI6CXzprC
February 1st 2020, 9:02am
BertrandBio @BertrandBio
B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 5/x site qualifi… https://t.co/OLxnFOOfY7
February 1st 2020, 9:02am
BertrandBio @BertrandBio
B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 4/x Kite Konnect… https://t.co/63HV44X1tl
February 1st 2020, 9:02am
BertrandBio @BertrandBio
B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 3/x process dev.… https://t.co/78u53zBxwH
February 1st 2020, 9:02am
BertrandBio @BertrandBio
B Dudek $KITE / $GILD Expanding CAR T into the commercial setting: Planning for success #CART2020 2/x west coast f… https://t.co/phCcVX5NOm
February 1st 2020, 9:02am
BertrandBio @BertrandBio
B Dudek Head Quality EU @ $KITE / $GILD - Expanding CAR T into the commercial setting: Planning for success… https://t.co/1ZgncTYQWs
February 1st 2020, 9:02am
BertrandBio @BertrandBio
$GILD $KITE symposium intro A Sureda - Defining long-term survival in DLBCL #CART2020 1/x https://t.co/5LiV4vC1KA
January 31st 2020, 7:01am
Gambiste1 @Gambiste1
RT @BertrandBio: S Lykopoulos - ARE CAR TS THE SAME? EVIDENCE FROM EUROPEAN HTA REVIEWS #CART2020 $GILD $KITE 1/x review of EU authorities…
January 31st 2020, 6:01am
Gambiste1 @Gambiste1
RT @BertrandBio: S Lykopoulos - ARE CAR TS THE SAME? EVIDENCE FROM EUROPEAN HTA REVIEWS #CART2020 $GILD $KITE 2/x negative HTA in Denmark…
January 31st 2020, 6:01am
Gambiste1 @Gambiste1
RT @BertrandBio: S Lykopoulos - ARE CAR TS THE SAME? EVIDENCE FROM EUROPEAN HTA REVIEWS #CART2020 $GILD $KITE 3/x more favourable HTA for…
January 31st 2020, 6:01am
BertrandBio @BertrandBio
S Lykopoulos - ARE CAR TS THE SAME? EVIDENCE FROM EUROPEAN HTA REVIEWS #CART2020 $GILD $KITE 3/x more favourable H… https://t.co/SNivnWahDU
January 31st 2020, 6:01am
BertrandBio @BertrandBio
S Lykopoulos - ARE CAR TS THE SAME? EVIDENCE FROM EUROPEAN HTA REVIEWS #CART2020 $GILD $KITE 2/x negative HTA in D… https://t.co/P7feyEMT5d
January 31st 2020, 6:01am
BertrandBio @BertrandBio
S Lykopoulos - ARE CAR TS THE SAME? EVIDENCE FROM EUROPEAN HTA REVIEWS #CART2020 $GILD $KITE 1/x review of EU auth… https://t.co/Gmc6g7s6Sp
January 31st 2020, 6:01am
_don_sparrow @_don_sparrow
@Crypto_Emir @handcashapp $kite is here to receive a dong.
January 26th 2020, 10:01am
ohmsonite @ohmsonite
@XBIObserver Yeah, I was right to be skeptical about $KITE's potential but I was wrong about a big pharma/biotech b… https://t.co/YM4HerHYXf
January 25th 2020, 11:01am
_don_sparrow @_don_sparrow
@riverish333 $kite is here to exchange BSV. Thanks ?
January 24th 2020, 8:01pm
_don_sparrow @_don_sparrow
@Toshi_Kamoto $Kite. Thanks.?
January 22nd 2020, 12:01am
PredatorDiaries @PredatorDiaries
@biotechhack That also means not doing the wrong one too. Arguably, not another $KITE? Although fair's fair, at t… https://t.co/bgboJirD6S
January 13th 2020, 12:01pm
RCR52 @RCR52
On a Side note I am documented on Twitter predicting $Kite and $Arry for over a year before their acquisitions
January 2nd 2020, 1:01pm
BigChodu @BigChodu
@abbynac Hold on to $kite for survival
December 31st 2019, 10:12am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.